Whitepaper: Single-use systems underline the rising significance of extractables and leachables studies
Posted: 3 December 2020 | Merck | No comments yet
Single-use systems come with their own extractables and leachables challenges. Although there are no formal guidelines yet, safety must be assessed.
Testing for leachables (substances that migrate under normal conditions) and extractables (those that migrate when exposed to solvent under harsh conditions) is critical for the pharmaceutical industry. Although formal guidelines for E&L assessments have not yet been enacted for Single Use Systems, there is a regulatory expectation that tests will be performed. The FDA’s Center for Biologics Evaluation and Research recommends a risk-based approach to evaluation.
Related content from this organisation
- Pursuing new paths in targeted protein degradation drug development
- Efficient shutdown recovery: leveraging RMM to unlock value and ensure environmental quality
- Improved outcome for prostate cancer patients in Phase III PROpel trial
- Testing non-inferiority for accuracy of quantitative microbiological methods
- QA/QC Microbiology/RMM In-Depth Focus 2022
Related topics
Analytical techniques, Biopharmaceuticals, Formulation, Manufacturing, Packaging, QA/QC, Regulation & Legislation, Research & Development (R&D)
